Long-Term Data Support Early GA Intervention

New data from the GATHER2 open-label extension, presented during retina subspecialty day at AAO, emphasizes the value of starting treatment early to preserve retinal tissue.

By: Arshad M. Khanani, MD, MA, FASRS, Diana V. Do, MD

Retinal Physician October 18, 2025

-0:00/0:00

Diana V. Do, MD

Retina Specialist

Specialties: Ophthalmology

Bio: Diana V. Do, MD, is a retina specialist and author for Retinal Physician. Her work focuses on ophthalmology and retinal disease, with interest in clinical trials, practice management, and emerging therapies for retinal conditions. In her Retinal Physician column, Dr. Do discusses developments in retina care, including clinical research collaboration, international clinical trial infrastructure, and investigational treatments for neovascular age-related macular degeneration and diabetic macular edema. She has also referenced her training connections with the Wilmer Eye Institute.

PentaVision

Retinal Physician

Long-Term Data Support Early GA Intervention

Recommendations